Story · Medicine & Biotech

New strategy may target common cancer driver with minimal side effects

1 outlet · first reported by Medical Xpress 9d ago

Coverage, in order

  1. 9d ago
    New strategy may target common cancer driver with minimal side effects

    Researchers have found a surprisingly common vulnerability in a broad variety of cancers and have begun designing drug compounds to exploit it, in a study led by investigators at Weill Cornell Medicine. The findings suggest the possibility of a potent, low-side-effect treatment that could benefit…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.